TRIP.COM-S
09961
TME-SW
01698
NTES-S
09999
XIAOMI-W
01810
MEITUAN-W
03690
HK Stock MarketDetailed Quotes
00570 TRAD CHI MED
- 2.330
- -0.060-2.51%
Not Open Dec 4 16:08 CST
11.73BMarket Cap11.65P/E (TTM)
2.390High2.310Low42.44MVolume2.390Open2.390Pre Close99.08MTurnover0.84%Turnover Ratio8.26P/E (Static)5.04BShares4.46052wk High0.50P/B11.73BFloat Cap2.12052wk Low--Dividend TTM5.04BShs Float7.108Historical High--Dividend LFY3.35%Amplitude-0.532Historical Low2.334Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
TRAD CHI MED Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 45.76%1.22B | ---- | -66.67%840.11M | ---- | 13.01%2.52B | ---- | 3.50%2.23B | ---- | 16.05%2.15B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 2.99%-65.26M | ---- | -7.50%-67.27M | ---- | -31.46%-62.58M | ---- | 7.12%-47.6M | ---- | -18.51%-51.25M |
| Attributable subsidiary (profit) loss | ---- | 6.32%3.7M | ---- | -67.63%3.48M | ---- | -32.29%10.75M | ---- | 214.27%15.87M | ---- | -28.13%5.05M |
| Impairment and provisions: | ---- | -81.76%39.79M | ---- | 124.96%218.1M | ---- | 532.30%96.95M | ---- | -60.54%15.33M | ---- | 166.08%38.86M |
| -Impairment of property, plant and equipment (reversal) | ---- | -84.62%20.77M | ---- | 1,016.32%135.08M | ---- | --12.1M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -60.84%9.65M | ---- | -34.81%24.63M | ---- | 146.42%37.78M | ---- | -60.54%15.33M | ---- | 166.08%38.86M |
| -Impairment of trade receivables (reversal) | ---- | -20.28%8.78M | ---- | -21.78%11.01M | ---- | --14.08M | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | 20.46%35.87M | ---- | --29.78M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -94.90%587K | ---- | 258.77%11.51M | ---- | --3.21M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13,725.00%-553K | ---- | 98.96%-4K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13,725.00%-553K | ---- | 98.96%-4K |
| Asset sale loss (gain): | ---- | -610.41%-33.72M | ---- | 80.65%-4.75M | ---- | -28,757.65%-24.53M | ---- | 99.65%-85K | ---- | -797.77%-24.57M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 102.10%128K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -454.92%-26.34M | ---- | 80.68%-4.75M | ---- | -7,626.10%-24.57M | ---- | -104.31%-318K | ---- | 120.28%7.39M |
| -Loss (gain) from selling other assets | ---- | ---7.38M | ---- | ---- | ---- | -82.83%40K | ---- | 100.73%233K | ---- | ---32.09M |
| Depreciation and amortization: | ---- | 6.83%1.09B | ---- | 25.61%1.02B | ---- | 27.33%813.32M | ---- | 14.13%638.74M | ---- | 11.79%559.68M |
| -Depreciation | ---- | 3.08%1.13B | ---- | 29.40%1.1B | ---- | 24.20%849.6M | ---- | 15.78%684.08M | ---- | 15.93%590.83M |
| -Other depreciation and amortization | ---- | 46.20%-41.84M | ---- | -114.40%-77.78M | ---- | 20.00%-36.28M | ---- | -45.56%-45.34M | ---- | -246.16%-31.15M |
| Financial expense | ---- | -9.81%199.05M | ---- | -0.60%220.7M | ---- | -9.25%222.03M | ---- | -18.73%244.67M | ---- | 2.99%301.05M |
| Exchange Loss (gain) | ---- | 228.21%384K | ---- | 115.29%117K | ---- | 42.78%-765K | ---- | -110.22%-1.34M | ---- | 234.53%13.08M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39.64%69.78M | ---- | 155.13%49.97M |
| Operating profit before the change of operating capital | ---- | 10.20%2.46B | ---- | -37.57%2.23B | ---- | 12.97%3.58B | ---- | 3.89%3.16B | ---- | 20.67%3.05B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 106.94%70.94M | ---- | -493.32%-1.02B | ---- | 21.06%-172.19M | ---- | 11.98%-218.14M | ---- | 61.29%-247.83M |
| Accounts receivable (increase)decrease | ---- | -292.14%-1.39B | ---- | 117.66%722.67M | ---- | -150.02%-4.09B | ---- | -725.33%-1.64B | ---- | -218.41%-198.32M |
| Accounts payable increase (decrease) | ---- | 189.26%927.01M | ---- | -155.96%-1.04B | ---- | 484.92%1.86B | ---- | -174.15%-482.2M | ---- | 218.24%650.31M |
| Special items for working capital changes | ---- | -233.09%-637.04M | ---- | 729.07%478.65M | ---- | 128.41%57.73M | ---- | 82.76%-203.19M | ---- | -649.25%-1.18B |
| Cash from business operations | ---- | 4.30%1.43B | ---- | 12.13%1.37B | ---- | 96.08%1.22B | ---- | -69.86%624.59M | ---- | 39.40%2.07B |
| China income tax paid | ---- | 6.19%-263.48M | ---- | 34.48%-280.88M | ---- | -8.22%-428.69M | ---- | 18.69%-396.11M | ---- | -64.52%-487.19M |
| Special items of business | 192.05%569.7M | ---- | -345.85%-618.9M | ---- | 356.14%251.74M | ---- | 94.59%-98.28M | ---- | -25.32%-1.82B | ---- |
| Net cash from operations | 192.05%569.7M | 7.00%1.17B | -345.85%-618.9M | 37.23%1.09B | 356.14%251.74M | 248.41%796.03M | 94.59%-98.28M | -85.59%228.47M | -25.32%-1.82B | 33.15%1.59B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -47.86%16.32M | -2.99%65.26M | 34.70%31.3M | 7.50%67.27M | -4.58%23.24M | 31.46%62.58M | 13.28%24.35M | -7.12%47.6M | -15.92%21.5M | 18.51%51.25M |
| Decrease in deposits (increase) | 107.49%44.5M | -2,818.17%-135.23M | -150.29%-594.25M | -97.98%4.98M | -211.60%-237.42M | 2,341.76%246.37M | 36.22%212.75M | 103.51%10.09M | 146.32%156.18M | -223.57%-287.36M |
| Sale of fixed assets | -26.57%876K | 221.05%45.12M | -43.11%1.19M | -56.12%14.05M | -87.46%2.1M | 383.10%32.03M | 15,985.58%16.73M | 116.42%6.63M | -95.54%104K | -59.55%3.06M |
| Purchase of fixed assets | 14.37%-226.19M | 7.61%-483.93M | -11.28%-264.14M | 33.45%-523.79M | 44.46%-237.37M | 30.32%-787.09M | 7.94%-427.38M | -21.70%-1.13B | 13.99%-464.23M | 3.43%-928.19M |
| Selling intangible assets | ---- | 265,250.00%10.61M | ---- | --4K | ---- | ---- | --301K | ---- | ---- | --37.4M |
| Purchase of intangible assets | 3.16%-1.32M | -34.35%-4.69M | -6.57%-1.36M | 96.13%-3.49M | -294.44%-1.28M | 26.61%-90.1M | 99.54%-324K | 49.92%-122.77M | -802.68%-70.66M | -4,797.12%-245.15M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---12K | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | --501K | --501K | ---- | ---- | 84.03%-16M | ---13.83M | -11,167.96%-100.17M | ---- | 100.23%905K |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -94.54%73.35M | -93.89%73.35M | -50.58%1.34B |
| Cash on investment | 93.14%-24K | -113.53%-568K | -100.00%-350K | 95.97%-266K | 93.13%-175K | 51.78%-6.59M | 97.48%-2.55M | 99.07%-13.68M | 92.51%-101.16M | 51.19%-1.47B |
| Other items in the investment business | -76.70%583K | -62.29%25.3M | -81.38%2.5M | 206.61%67.08M | 69.57%13.44M | -85.80%21.88M | -87.00%7.93M | 35.45%154.1M | 654.63%60.98M | 73.54%113.77M |
| Net cash from investment operations | 79.96%-165.25M | -27.65%-477.62M | -88.49%-824.6M | 30.32%-374.15M | -140.36%-437.49M | 50.03%-536.94M | 43.81%-182.02M | 22.38%-1.07B | 67.63%-323.93M | 10.46%-1.38B |
| Net cash before financing | 128.02%404.45M | -3.76%691.19M | -677.13%-1.44B | 177.20%718.21M | 33.73%-185.75M | 130.63%259.09M | 86.91%-280.3M | -521.38%-845.98M | 12.62%-2.14B | 156.47%200.77M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 11.48%3.19B | 1.57%3.81B | -1.99%2.86B | 29.44%3.75B | 24.89%2.92B | -48.83%2.9B | 21.80%2.34B | 381.04%5.66B | 107.90%1.92B | -37.08%1.18B |
| Refund | -149.50%-2.22B | 30.16%-2.54B | 49.69%-888.41M | -18.89%-3.64B | -17.60%-1.77B | 33.26%-3.06B | -73.07%-1.5B | -125.68%-4.58B | 7.98%-867.69M | -38.06%-2.03B |
| Issuance of bonds | ---- | 0.00%3B | 10.00%2.2B | 200.00%3B | 100.00%2B | -68.75%1B | -54.55%1B | 14.29%3.2B | --2.2B | --2.8B |
| Interest paid - financing | -1.63%-108.72M | 13.53%-177.91M | 18.83%-106.98M | -0.57%-205.76M | 16.76%-131.79M | 24.20%-204.59M | -36.79%-158.33M | 13.68%-269.9M | 7.39%-115.75M | -10.43%-312.69M |
| Dividends paid - financing | 98.91%-2.61M | 17.02%-333.92M | -398.28%-240.18M | -18.73%-402.4M | -30,406.96%-48.2M | -2.63%-338.93M | 99.67%-158K | 38.65%-330.25M | 79.90%-48.53M | -6.35%-538.34M |
| Absorb investment income | ---- | ---- | ---- | -84.21%1.5M | -81.25%1.5M | -92.96%9.5M | -87.98%8M | -56.72%134.99M | -60.91%66.57M | 154.28%311.88M |
| Issuance expenses and redemption of securities expenses | 63.70%-800M | -39.96%-4.2B | -119.83%-2.2B | -198.18%-3B | 0.48%-1B | 79.05%-1.01B | 49.63%-1.01B | -92.35%-4.81B | ---2B | -100,422.72%-2.5B |
| Other items of the financing business | ---- | -189.18%-111.99M | ---- | -7,691.75%-38.73M | -5,348.39%-27.13M | ---497K | ---498K | ---- | ---- | 87.40%-16.7M |
| Net cash from financing operations | -97.07%47.07M | -4.85%-584.31M | -16.81%1.61B | 23.06%-557.28M | 189.09%1.93B | 28.60%-724.32M | -41.63%668.96M | 10.03%-1.01B | 578.85%1.15B | -163.62%-1.13B |
| Effect of rate | -76.37%95K | -60.70%373K | -46.18%402K | 134.89%949K | 1,145.00%747K | -9,814.29%-2.72M | -97.93%60K | 100.94%28K | 4,356.92%2.9M | -110.41%-2.98M |
| Net Cash | 173.19%451.52M | -33.58%106.88M | -90.55%165.28M | 134.59%160.93M | 349.79%1.75B | 74.99%-465.22M | 139.02%388.66M | -100.73%-1.86B | 62.98%-995.97M | -165.42%-926.82M |
| Begining period cash | 3.72%2.99B | 5.96%2.88B | 5.96%2.88B | -14.69%2.72B | -14.69%2.72B | -36.87%3.19B | -36.87%3.19B | -15.56%5.05B | -15.56%5.05B | 31.90%5.98B |
| Cash at the end | 12.91%3.44B | 3.72%2.99B | -31.82%3.05B | 5.96%2.88B | 24.96%4.47B | -14.69%2.72B | -11.81%3.57B | -36.87%3.19B | 23.37%4.05B | -15.56%5.05B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
